[AVP: a new target in the treatment of chronic kidney disease?].
CNR-IBIM, Ospedali Riunioni, Reggio Calabria, Italy. netdavi@tiscali.it
Davide
D
Bolignano
D050034:Antidiuretic Agents / Q000037:antagonists & inhibitors*; D051399:Aquaporin 2 / Q000096:biosynthesis; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors*; D006706:Homeostasis / Q000187:drug effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000378:metabolism; D007684:Kidney Tubules / Q000378:metabolism
D050034:Antidiuretic Agents; D051399:Aquaporin 2; D001127:Arginine Vasopressin